Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.

scientific article published in September 1998

Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9777891

P50authorFrederick R. AppelbaumQ75025725
P2093author name stringAnderson J
P921main subjectmyelodysplastic syndromeQ954625
P304page(s)S25-9
P577publication date1998-09-01
P1433published inLeukemiaQ6534498
P1476titleAllogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score
P478volume12 Suppl 1

Reverse relations

cites work (P2860)
Q36402045A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.
Q50079881Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation
Q34996203Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis
Q36768610Azacitidine in the management of patients with myelodysplastic syndromes
Q36608689CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse
Q39214508Cancer Care at Times of Crisis and War: The Syrian Example
Q46654906Comparison of 2 preparative regimens for stem cell transplantation from HLA-matched sibling donors in patients with advanced myelodysplastic syndrome
Q43166941Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome
Q50778042Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.
Q35925067Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematol
Q34272525Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a [...]
Q35739130Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY
Q33389333Management of myelodysplastic syndromes in the geriatric patient
Q37448906Managing myelodysplastic symptoms in elderly patients.
Q36683757Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome
Q39276603Monosomal karyotype in myeloid neoplasias: a literature review
Q36110604Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C
Q38965973Myelodysplastic Syndromes: Updates and Nuances
Q43082895Myelodysplastic syndrome: An update on diagnosis and therapy
Q37244697Myelodysplastic syndrome: an update on diagnosis and therapy
Q35291851Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).
Q35193735Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Q36920394Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and M
Q37738511Stem cell transplantation for myelodysplastic syndromes: the lure of a cure.
Q41902244Stem cells in hemato-oncology
Q34996351The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).
Q34418429The role of azacitidine in the management of myelodysplastic syndromes (MDS).
Q30240238Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens
Q35838113Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
Q45756342Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.

Search more.